Characterization of Breast Masses Incidentally Detected on Chest CT
NCT ID: NCT02755779
Last Updated: 2016-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2016-06-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this study is to investigate the incidence and appearance of incidentally discovered breast masses on chest CT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breast Lesion in CT Chest
NCT06196216
Use of Bone Scintigraphy, CT and MRI in Breast Cancer
NCT00682253
Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy
NCT05141279
Whole-body MRI for the Detection of Metastasis
NCT02183597
Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions
NCT01004666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known breast cancer
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel Aviv Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yoav Amitai
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yoav Amitai, Dr
Role: PRINCIPAL_INVESTIGATOR
Sourasky medical center Tel aviv
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0067-16-TLV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.